Yesterday, March 3, 2016, 128 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $7.31 to $24,274,480.00.

Highlighted Stocks Traded by Insiders:

Trex (TREX) - FREE Research Report

Gerhard Christopher Paul, who is Vice President, Sales at Trex, sold 3,030 shares at $43.81 on March 3, 2016. Following this transaction, the Vice President, Sales owned 20,601 shares meaning that the stake was reduced by 12.82% with the 3,030-share transaction.

The shares most recently traded at $43.79, down $0.02, or 0.05% since the insider transaction. Historical insider transactions for Trex go as follows:

  • 4-Week # shares sold: 2,037
  • 12-Week # shares sold: 2,037
  • 24-Week # shares sold: 68,602

The average volume for Trex has been 504,000 shares per day over the past 30 days. Trex has a market cap of $1.3 billion and is part of the industrial goods sector and materials & construction industry. Shares are up 15.75% year-to-date as of the close of trading on Thursday.

Trex Company, Inc. manufactures and distributes wood/plastic composite products, and related accessories primarily for the residential and commercial decking, and railing applications in the United States. The company has a P/E ratio of 28.9. Currently, there are 4 analysts who rate Trex a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TREX - FREE

TheStreet Quant Ratings

rates Trex as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, impressive record of earnings per share growth, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Trex Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Parexel International (PRXL) - FREE Research Report

Lindop Christopher J, who is Director at Parexel International, sold 2,000 shares at $60.28 on March 3, 2016. Following this transaction, the Director owned 18,255 shares meaning that the stake was reduced by 9.87% with the 2,000-share transaction.

The shares most recently traded at $61.31, up $1.03, or 1.68% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 1,330
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 3,530
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 5,030

The average volume for Parexel International has been 668,600 shares per day over the past 30 days. Parexel International has a market cap of $3.3 billion and is part of the health care sector and health services industry. Shares are down 10.54% year-to-date as of the close of trading on Thursday.

PAREXEL International Corp, a biopharmaceutical services company, provides clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology products and services for pharmaceutical, biotechnology, and medical device industries worldwide. The company has a P/E ratio of 24.8. Currently, there are 6 analysts who rate Parexel International a buy, 1 analyst rates it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings

rates Parexel International as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, notable return on equity, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Parexel International Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Alexandria Real Estate Equities (ARE) - FREE Research Report

Marcus Joel S, who is Chief Executive Officer at Alexandria Real Estate Equities, sold 5,000 shares at $80.45 on March 3, 2016. Following this transaction, the Chief Executive Officer owned 616,770 shares meaning that the stake was reduced by 0.8% with the 5,000-share transaction.

The shares most recently traded at $83.28, up $2.83, or 3.4% since the insider transaction. Historical insider transactions for Alexandria Real Estate Equities go as follows:

  • 4-Week # shares bought: 2,500
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 2,500
  • 12-Week # shares sold: 26,528
  • 24-Week # shares bought: 2,500
  • 24-Week # shares sold: 54,028

The average volume for Alexandria Real Estate Equities has been 471,000 shares per day over the past 30 days. Alexandria Real Estate Equities has a market cap of $6.0 billion and is part of the financial sector and real estate industry. Shares are down 8.44% year-to-date as of the close of trading on Thursday.

Alexandria Real Estate Equities, Inc., a real estate investment trust (REIT), engages in the ownership, operation, management, development, acquisition, and redevelopment of properties for the life sciences industry. The stock currently has a dividend yield of 3.8%. The company has a P/E ratio of 49.8. Currently, there are 4 analysts who rate Alexandria Real Estate Equities a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ARE - FREE

TheStreet Quant Ratings

rates Alexandria Real Estate Equities as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself and poor profit margins. Get the full

Alexandria Real Estate Equities Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.